Bugworks

Linked-in

Our Platform

GYROX – Dual Targeting Novel Broad Spectrum Antibacterial Agents

We strive towards a world where casualties because of bacterial resistance don’t become the norm, through our first & best-in-class broad spectrum antibacterial agents.
gyrox

DARE: Dual acting Adenosine Receptor antagonist Efficacy platform

We are developing novel immuno-oncology small molecule agents targeting the adenosine A2A/A2B receptors.

Publications

PUBLICATIONS-CTA
to top